Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Esophageal Neoplasms × rilotumumab × Clear all

Sponsor

Conditions

Recurrence 2 Small Cell Lung Carcinoma 1 Recurrent Squamous Cell Lung Carcinoma 1 Rectal Neoplasms 1 Pleural Effusion, Malignant 1 Ovarian Neoplasms 1 MET Positive 1 Lung Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Fluorouracil 32 Cisplatin 32 Radiotherapy 29 Oxaliplatin 28 Paclitaxel 20 Irinotecan 20 Docetaxel 20 pembrolizumab 19 Leucovorin 18 Capecitabine 16 Cetuximab 11 Bevacizumab 11 Carboplatin 10 Radiation 9 Trastuzumab 8 Surgical Procedures, Operative 8 Panitumumab 6 Epirubicin 5 Neoadjuvant Therapy 4 Esophagectomy 4 Erlotinib Hydrochloride 4 tisotumab vedotin 3 durvalumab 3 Sunitinib 3 Gemcitabine 3 Chemotherapy, Adjuvant 3 Albumin-Bound Paclitaxel 3 pegfilgrastim 2 niraparib 2 epacadostat 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡